Skip to main content
. 2021 Aug 15;13(8):9143–9151.

Table 2.

Univariate analysis of delirium with different clinical phenotypes (n = 639)

Clinical Phenotype Overall Cohort (n = 639) n (%) Never deliriums (n = 439) n (%) Ever deliriums (n = 200) n (%) F P Value
Hypoxic1 100.28 0.000**
    No 426 (66.7) 348 (79.3) 78 (39.0)
    Yes 213 (33.3) 91 (20.7) 122 (61.0)
Septic2 16.01 0.000**
    No 532 (83.3) 383 (87.2) 149 (74.5)
    Yes 107 (16.7) 56 (12.8) 51 (25.5)
Metabolic3
    No 463 (72.5) 369 (84.1) 94 (47.0) 94.53 0.000**
    Yes 176 (27.5) 70 (15.9) 106 (53.0)
Sedative-associated4
    None 367 (57.4) 273 (62.2) 94 (47.0) 23.18 0.000**
    No benzodiazepines 134 (21.0) 94 (21.4) 40 (20.0)
    Benzodiazepines 138 (21.6) 72 (16.4) 66 (33.0)
co-exist 140.15 0.000**
    1 type 235 (36.8) 184 (41.9) 51 (25.5)
    2 types 142 (22.2) 58 (13.2) 84 (42.0)
    3-4 types 73 (11.4) 26 (5.9) 47 (23.5)
    unclassified 189 (29.6) 171 (39.0) 18 (9.0)
**

P < 0.01.

1

Hypoxia (PaO2 < 80 mmHg) or shock.

2

Known sepsis or systemic inflammatory response syndrome criteria.

3

Blood urea nitrogen > 6.4 mmol/L or serum creatinine > 62 μmol/L.

4

Receipt of benzodiazepine or propofol or dexmedetomidine.